To unravel chemotherapy resistance mechanisms present in LSCs, several studies compared the gene expression signature of CD34+CD38− LSCs or functionally defined LSCs with that of non-LSC compartments, AML blasts or leukemic progenitors [11,17,18,19]. Here, CD34 is linked to acute myeloid leukemia.